Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Weight Watchers International Inc (NQ: WW )

1.599 -0.061 (-3.70%)
Streaming Delayed Price Updated: 9:31 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Weight Watchers International Inc

LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
WW International Inc. (WW) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). 
Via MarketBeat
WW International Inc. (WW) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
Via Investor Brand Network
GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
EQNX::TICKER_START (NASDAQ:LEXX),(NASDAQ:AMGN),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:WW) EQNX::TICKER_END 
Via FinancialNewsMedia
MarketBeat Week in Review – 1/1 - 1/5
Stocks finished the week looking for direction after a hotter-than-expected Jobs report and as investors wait for inflation information and big bank earnings 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Weight Watchers gains from Oprah’s GLP-1 weight-loss
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ozempic vs. Mounjaro:: Battle of the bulge
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage 
Via MarketBeat
Exposures Product Safety
2 Stocks That Raised EPS but Lowered Revenue Estimates
Growth or value? Top or bottom line? While investing in stocks with both is preferable, they tend to be expensive. Stocks that meet 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Recovery in Teladoc is Showing Signs of Life
The world’s largest virtual healthcare services provider Teladoc Health Inc. (NYSE: TDOC) stock is finally breaking out of its year-long bearish weekly descend 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Weight Watchers International Inc. (NASDAQ: WW) Sets New 52-Week High in Wednesday Session
Via Investor Brand Network
Accolade: A Rising Personalized AI-Powered Healthcare Platform
Accolade Inc. (NASDAQ: ACCD) provides an artificial intelligence (AI)-powered healthcare platform. Learn more about Accolade Inc. stock. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
WW International Inc. (NASDAQ: WW) Making Surprising Moves in Friday Session
Via Investor Brand Network
The Turnaround for Weight Watchers is Taking Shape
Weight management meals and services provider WW International Inc. (NYSE: WW) stock made a 52-week high of $10.02 after its Q1 2023 earnings release. Shares 
Via MarketBeat
Can Teladoc Stock Be Resuscitated?
Virtual healthcare services company Teladoc Health Inc. (NYSE: TDOC) has had a treacherous journey rising to a high of $308 in Feb 2021 and falling to a post- 
Via MarketBeat
Exposures COVID-19
Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs
The topic of weight loss drugs has been making recent headlines. The positive phase 1 clinical trial for Viking Therapeutics Inc. (NASDAQ: VKTX) GLP-1 treatme 
Via MarketBeat
MarketBeat Week in Review – 4/10 - 4/14
The market continues to seek direction, but the MarketBeat analysts are helping you find opportunities. Here are some of this week's most popular articles. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Weight Watchers Reshapes Itself with a Game-Changer Acquisition
Weight management meals and services provider WW International Inc. (NYSE: WW) spike over 25% as it closed its acquisition of telehealth weight loss platform 
Via MarketBeat
WW International Inc. (NASDAQ: WW) Near Top of Volume Charts in Tuesday Trading
Via Investor Brand Network
WeightWatchers (NASDAQ: WW) Announces Acquisition of Sequence in Shift to Obesity Drug Market
WW International, Inc. (NASDAQ: WW), or WeightWatchers, describes itself as a human-focused technology company that offers a “proven, science-based, clinically 
Via Spotlight Growth
WW Schedules Third Quarter 2022 Earnings Conference Call
From WW International Inc.
Via GlobeNewswire
Desperate for Solutions, Diabetes and Obesity Healthcare Sectors Find Answers, Hope in Innovative Tech
Via Investor Brand Network
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.